The challenge of viral reservoirs in HIV-1 infection

被引:486
|
作者
Blankson, JN [1 ]
Persaud, D
Siliciano, RF
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
来源
ANNUAL REVIEW OF MEDICINE | 2002年 / 53卷
关键词
AIDS; latency; HAART; sanctuary; persistence;
D O I
10.1146/annurev.med.53.082901.104024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A viral reservoir is a cell type or anaton-deal site in association with which a replication-competent form of the virus accumulates and persists with more stable kinetic properties than the main pool of actively replicating virus. This article reviews several cell types and anatomical sites proposed as potential reservoirs for HIV-1. It is now clear that HIV-1 persists in a small reservoir of latently infected resting memory CD4+ T cells, which shows minimal decay even in patients on highly active antiretroviral therapy (HAART). The persistence of virus in this reservoir is consistent with the biology of these cells and the long-term persistence of immunologic memory. The viral replication that continues in patients on suppressive HAART may also contribute to the stability of this reservoir. There may be other reservoirs, but the latent reservoir in resting CD4+ T cells appears to be sufficient to guarantee lifetime persistence of HIV-1 in the majority of patients on current HAART regimens, and unless new approaches are developed, eradication will not be possible. The clinical implications of this and other HIV-1 reservoirs are discussed.
引用
收藏
页码:557 / 593
页数:37
相关论文
共 50 条
  • [31] Positive DAMPs - HIV-1 Feedback: A Vicious Circle from the Original Infection to the Establishment of viral Reservoirs
    Heil, M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 44 - 45
  • [32] Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral Reservoirs
    Pasquereau, Sebastien
    Kumar, Amit
    Herbein, Georges
    VIRUSES-BASEL, 2017, 9 (04):
  • [33] Initiation of antiretroviral therapy during recent HIV-1 infection results in lower residual viral reservoirs
    Pires, A
    Hardy, G
    Gazzard, B
    Gotch, F
    Imami, N
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) : 783 - 790
  • [34] Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies
    Eriksson, Susanne
    Graf, Erin H.
    Dahl, Viktor
    Strain, Matthew C.
    Yukl, Steven A.
    Lysenko, Elena S.
    Bosch, Ronald J.
    Lai, Jun
    Chioma, Stanley
    Emad, Fatemeh
    Abdel-Mohsen, Mohamed
    Hoh, Rebecca
    Hecht, Frederick
    Hunt, Peter
    Somsouk, Ma
    Wong, Joseph
    Johnston, Rowena
    Siliciano, Robert F.
    Richman, Douglas D.
    O'Doherty, Una
    Palmer, Sarah
    Deeks, Steven G.
    Siliciano, Janet D.
    PLOS PATHOGENS, 2013, 9 (02):
  • [35] Identification and Characterization of HIV-1 Latent Viral Reservoirs In Peripheral Blood
    Chargin, Amanda
    Yin, Fangfang
    Song, Min
    Subramaniam, Srividyabhuvaneswari
    Knutson, Grace
    Patterson, Bruce K.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (01) : 60 - 66
  • [36] HIV-1 Latency and Eradication of Long-term Viral Reservoirs
    Coiras, Mayte
    Rosa Lopez-Huertas, Maria
    Alcami, Jose
    DISCOVERY MEDICINE, 2010, 9 (46) : 185 - 191
  • [37] The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs
    Kelly A. Metcalf Pate
    Joel N. Blankson
    Retrovirology, 14
  • [38] The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs
    Pate, Kelly A. Metcalf
    Blankson, Joel N.
    RETROVIROLOGY, 2017, 14
  • [39] Salvage therapy for HIV-1 infection - the challenge grows
    Mellors, J
    Montaner, J
    LANCET, 2000, 355 (9213): : 1435 - 1435
  • [40] Viral and host determinants of neurovirulence of HIV-1 infection
    Fujimura, RK
    Shapshak, P
    Segal, DM
    Crandall, KA
    Goodkin, K
    Page, JB
    Douyon, R
    Zhang, BT
    Xin, KQ
    de la Vega, PR
    Nagano, I
    Srivastava, A
    DRUGS OF ABUSE, IMMUNOMODULATION, AND AIDS, 1998, 437 : 241 - 253